Trabectedin
HealthData.Gov
Updated Oct 29, 2026
About this dataset
YONDELIS (trabectedin) is a prescription intravenous alkylating drug used in cancer treatment. It's manufactured by Janssen Products, LP as a lyophilized powder for injection, with each vial containing 1 mg of trabectedin. Approved under NDA207953, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Trabectedin
Access the FDA dataset for Trabectedin — ANDA 207953 submitted by Mylan Institutional LLC
Modified Apr 29, 2026